145P An engineered ligand-trap biologic targeting the CD47 signaling pathway for cancer treatment with superb efficacy and safety profiles

Z.S. Juo, J-T. Wang, C-L. Tseng, H-F. Teng, P-H. Kuo, Y-C. Cheng, Y-J. Chen, Y-H. Lu, T-K. Shen, H-F. Wang, P-L. Tsai, Y-C. Wu, C-H. Ho, W-T. Sun, Y-C. Li, Y-H. Lee
{"title":"145P An engineered ligand-trap biologic targeting the CD47 signaling pathway for cancer treatment with superb efficacy and safety profiles","authors":"Z.S. Juo, J-T. Wang, C-L. Tseng, H-F. Teng, P-H. Kuo, Y-C. Cheng, Y-J. Chen, Y-H. Lu, T-K. Shen, H-F. Wang, P-L. Tsai, Y-C. Wu, C-H. Ho, W-T. Sun, Y-C. Li, Y-H. Lee","doi":"10.1016/j.iotech.2023.100617","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":" 10","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100617","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
145P 一种针对 CD47 信号通路的工程配体捕获生物制剂,用于癌症治疗,具有极佳的疗效和安全性特征
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信